✦ LIBER ✦

Short course prednisolone is superior to udca in the control of cholestasis due to acute viral hepatitis a – A randomized controlled trial

✍ Scribed by George, Jeffey; Thomas, Varghese; Ramachandran, T.M.

Book ID: 123563946
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 82 KB
Volume: 3
Category: Article
ISSN: 0973-6883
DOI: 10.1016/j.jceh.2013.03.098

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-course Prednisolone Versus Ursodeo

Short-course Prednisolone Versus Ursodeoxycholic Acid in the Treatment of Cholestasis due to Acute Viral Hepatitis A—A Randomized Controlled Study

✍ George, Jeffey; Thomas, Varghese 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Oral prednisolone in the acute managemen

Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial

✍ Péter Csonka; Minna Kaila; Pekka Laippala; Marja Iso-Mustajärvi; Timo Vesikari; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Oral prednisolone in the acute managemen

Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: A randomized, placebo-controlled trial

✍ Miles Weinberger 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB

The effect of a short one-on-one nursing

The effect of a short one-on-one nursing intervention on knowledge, attitudes and beliefs related to response to acute coronary syndrome in people with coronary heart disease: A randomized controlled trial

✍ Sharon McKinley; Kathleen Dracup; Debra K. Moser; Barbara Riegel; Lynn V. Doerin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 488 KB

ChlVPP alternating with PABlOE is superi

ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial

✍ Hancock, B W; Gregory, W M; Cullen, M H; Hudson, G Vaughan; Burton, A; Selby, P; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l